(Q39992529)

16 September 2017

Drug controlled of Cushing's syndrome. Combined aminoglutethimide and metyrapone therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A179256

23 May 2022

author name string

D. F. Child

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A179256

23 May 2022

C. W. Burke

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A179256

23 May 2022

D. M. Burley

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A179256

23 May 2022

L. H. Rees

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A179256

23 May 2022

T. R. Fraser

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A179256

23 May 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=179256

23 May 2022

publication date

1 June 1976

1 reference

16 September 2017

1 reference

16 September 2017

82

1 reference

16 September 2017

2

1 reference

16 September 2017

330-341

1 reference

16 September 2017

Identifiers

1 reference